Іздеу

Шығарылым
Атауы
Авторлар
Том 31, № 35 (2024)
Recent Developments in Coumarin Derivatives as Neuroprotective Agents
Mishra P., Kumar A., Kaur K., Jaitak V.
PDF
(Eng)
Том 31, № 14 (2024)
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy
Cui Y., Zhang J., Zhang G.
PDF
(Eng)
Том 31, № 7 (2024)
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review
Sehrawat R., Rathee P., Khatkar S., Akkol E., Khayatkashani M., Nabavi S., Khatkar A.
PDF
(Eng)
Том 31, № 30 (2024)
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
Lukic N., Macvanin M., Gluvic Z., Rizzo M., Radak D., Suri J., Isenovic E.
PDF
(Eng)
Том 31, № 22 (2024)
Synthesis of β-Amino Carbonyl 6-(Aminomethyl)- and 6-(Hydroxymethyl)pyrazolopyrimidines for DPP-4 Inhibition Study
Chung C., Tseng C., Li S., Zeng W., Lin Y., Hu Y., Jiang W., Huang G., Tsai H., Wong F.
PDF
(Eng)
Том 31, № 36 (2024)
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
Metwally K., Abo-Dya N.
PDF
(Eng)
Том 31, № 5 (2024)
Imidazo[4,5-b]Pyridines: From Kinase Inhibitors to more Diversified Biological Properties
Jarmoni K., Misbahi K., Ferrières V.
PDF
(Eng)
Том 31, № 30 (2024)
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
De S.
PDF
(Eng)
Том 31, № 2 (2024)
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies
Sheikh K., Iqubal A., Alam M., Akhter M., Khan M., Ehtaishamul Haque S., Parvez S., Jahangir U., Amir M., Khanna S., Shaquiquzzaman M.
PDF
(Eng)
Том 31, № 20 (2024)
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
PDF
(Eng)
Том 31, № 38 (2024)
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors
Shihab W., Kubba A., Tahtamouni L., Saleh K., AlSakhen M., Kanaan S., Saleh A., Yasin S.
PDF
(Eng)
Том 31, № 3 (2024)
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present)
Beltran E., Serafini M., Alves I., Aragón Novoa D.
PDF
(Eng)
Том 31, № 2 (2024)
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu
Yaribeygi H., Maleki M., Sathyapalan T., Rizzo M., Sahebkar A.
PDF
(Eng)
Том 31, № 20 (2024)
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors
Du S., Fang Y., Zhang W., Rao G.
PDF
(Eng)
Том 31, № 29 (2024)
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials
Heydari B., Sahebnasagh A., Omrani M., Azimi S., Dehghani M., Salehi-Abargouei A., Farman F., Saghafi F.
PDF
(Eng)
Том 31, № 16 (2024)
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
González J., Salas-Sarduy E., Alvarez L., Valiente P., Arni R., Pascutti P.
PDF
(Eng)
Том 31, № 9 (2024)
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)
De S.
PDF
(Eng)
Том 31, № 34 (2024)
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
Khator R., Biharee A., Bhatia N., Kulkarni S., Singh Y., Karthikeyan C., Jain A., Thareja S.
PDF
(Eng)
Том 31, № 29 (2024)
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment
Ma C., Cui S., Xu R.
PDF
(Eng)
Том 31, № 16 (2024)
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis
Saha A., Pushpa , Moitra S., Basak D., Brahma S., Mondal D., Molla S., Samadder A., Nandi S.
PDF
(Eng)
Том 31, № 8 (2024)
Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases
Chen Y., Li X.
PDF
(Eng)
Том 31, № 33 (2024)
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021
Duncan C., Gunosewoyo H., Mocerino M., Payne A.
PDF
(Eng)
Том 31, № 27 (2024)
Small Molecule Inhibitors against the Bacterial Pathogen Brucella
Wu Y., Guo Y., Ma Y., Yu H., Wang Z.
PDF
(Eng)
Том 31, № 8 (2024)
A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases
Olatunde O., Yong J., Lu C., Ming Y.
PDF
(Eng)
Том 31, № 32 (2024)
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy
Vijayan Y., Sandhu J., Harikumar K.
PDF
(Eng)
Том 31, № 27 (2024)
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review
Cabeza M.
PDF
(Eng)
Том 31, № 12 (2024)
The Structure-property Relationships of Clinically Approved Protease Inhibitors
Choi K.
PDF
(Eng)
Том 31, № 7 (2024)
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
PDF
(Eng)
Том 31, № 30 (2024)
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer
Wang X., Jing H.
PDF
(Eng)
Том 31, № 24 (2024)
Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors
Olgen S., Kaleli S., Karaca B., Demirel U., Bristow H.
PDF
(Eng)
Нәтижелер 30 - 1/30
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>